Cite
HARVARD Citation
Alexander, J. et al. (2021). Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. Journal for immunotherapy of cancer. 9 (7), p. . [Online].